Long Island University at AAPS 2026 PharmSci 360

Oct 25–28, 2026 New Orleans, LA ~4k attendees Website

Long Island University brings 11 presentations to AAPS 2026 PharmSci 360 in New Orleans. Its work centres on repurposing approved drugs as BMX kinase inhibitors for glioblastoma and neuroblastoma, using computational screening and AI-guided nanoparticle design. Projects also include a dosing model that links two styles of pharmacokinetic modeling and a transdermal spray for asenapine.

OrganizationAAPS 2026 PharmSci 360 Attendance
Poster
Mon Oct 26
11:30am–12:30pm
A Material-Sparing Powder Rheology Framework for Early Prediction and Mitigation of Tablet Sticking in High-Drug-Load Formulations
Solution Center · Poster M1130-09-48
Formulation and Delivery - Chemical
Poster
Mon Oct 26
12:30pm–1:30pm
A New Approach Methodology (NAM)-Driven Computational Platform for Identification of FDA-Approved BMX Inhibitor Leads
Solution Center · Poster M1230-03-17
Formulation and Delivery - Biomolecular
Poster
Mon Oct 26
12:30pm–1:30pm
In Vitro Anticancer Validation of Two Virtually Repurposed FDA-Approved Drugs Against Pediatric Neuroblastoma Cells: A Foundation for FDA 505(b)(2) Oncology Development
Solution Center · Poster M1230-07-37
Preclinical, Clinical, and Translational Sciences
Poster
Mon Oct 26
1:30pm–2:30pm
An FDA MIDD and NAMs-Driven Middle-Out Dosing Platform: Bridging Bottom-Up PBPK and PopPK via Model Order Reduction for 505(b)(2) Repurposing
Solution Center · Poster M1330-07-41
Preclinical, Clinical, and Translational Sciences
Poster
Tue Oct 27
9:30am–10:30am
Development of Vitamin D3 Oil-Loaded Direct Compression Tablets Using a Co-Processed Excipient as a Carrier and Evaluation of Dissolution Performance
Solution Center · Poster T0930-03-14
Formulation and Delivery - Chemical
Poster
Tue Oct 27
12:30pm–1:30pm
AI-Based Design, Optimization, and Evaluation of a Combined Aripiprazole-Olanzapine Nanotherapeutic System as a Novel BMX Kinase Inhibitor
Solution Center · Poster T1230-03-13
Formulation and Delivery - Biomolecular
Poster
Tue Oct 27
12:30pm–1:30pm
Comparative Evaluation of Repurposed BMX-Targeted Kinase Inhibitors for Glioblastoma: An In Vitro Foundation for 505(b)(2) Drug Repurposing
Solution Center · Poster T1230-06-33
Preclinical, Clinical, and Translational Sciences
Poster
Tue Oct 27
12:30pm–1:30pm
Development, Optimization, and Pharmacokinetic Evaluation of a Metered-Dose Asenapine Maleate Transdermal Spray
Solution Center · Poster T1230-09-49
Formulation and Delivery - Chemical
Poster
Tue Oct 27
12:30pm–1:30pm
Evaluation of Gabapentin/Trazodone (GABA/TRAZ) Nanoparticle Formulations Against U87 Glioblastoma Cells
Solution Center · Poster T1230-03-15
Formulation and Delivery - Biomolecular
Poster
Tue Oct 27
3:30pm–4:30pm
Artificial Intelligence-Assisted Development and Experimental Validation of a Lithium Carbonate Quetiapine Polymeric Nanosystem Using Eudragit® L100 as a Potential BMX Kinase Inhibitor
Solution Center · Poster T1530-09-48
Formulation and Delivery - Biomolecular
Poster
Wed Oct 28
9:30am–10:30am
A cQbD-Based Development of a Combined Gabapentin-Trazodone Chitosan Nanosystem as a Novel BMX Kinase Inhibitor
Solution Center · Poster W0930-01-06
Formulation and Delivery - Biomolecular

Explore the full AAPS 2026 PharmSci 360 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full AAPS 2026 PharmSci 360 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Long Island University

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American Association of Pharmaceutical Scientists (AAPS). Submit a correction